Bio
Henry is an MD-PhD candidate and Knight-Hennessy Scholar in the Medical Scientist Training Program and the Biomedical Informatics Program, where he is advised by Professor Russ Altman. He develops machine-learning methods to study the effects of complex genetic variation on human disease mechanisms, with focus on neurological and ophthalmic disorders. His goal is to translate genomic discoveries into disease-modifying therapies.
He received an AB summa cum laude from Harvard University in 2017, where he studied genetic mechanisms of retinal development with Professor Joshua Sanes. He then graduated with an MPhil with distinction from the University of Cambridge as a Gates Cambridge Scholar. He previously worked at Leaps by Bayer and the Massachusetts Eye and Ear Infirmary and has received a number of awards related to research and teaching.
